ANI Pharmaceuticals, Inc.
ANIP
$82.72
-$0.05-0.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.28% | 3.28% | 211.35% | -45.48% | 252.60% |
| Total Depreciation and Amortization | -7.49% | -0.08% | -2.79% | 1.70% | 1.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.53% | -43.70% | 63.19% | 257.76% | -159.02% |
| Change in Net Operating Assets | 101.42% | -50.56% | -149.22% | 2,626.56% | 127.79% |
| Cash from Operations | 92.23% | -31.07% | -41.89% | 116.66% | 120.62% |
| Capital Expenditure | -388.26% | 79.62% | -52.04% | -62.25% | -3.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,201.89% | -165.00% | 97.93% | 83.34% | -20,100.00% |
| Cash from Investing | -707.13% | 77.24% | 10.80% | 65.19% | -85.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -100.05% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 5,694.74% | -99.61% | 688.24% | -50.99% | 49.06% |
| Repurchase of Common Stock | -3,133.22% | 41.48% | -89.47% | 94.49% | -3,045.60% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | 15.48% | -0.25% | 0.00% |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -366.26% | -173.07% | 463.19% | 82.36% | -101.87% |
| Foreign Exchange rate Adjustments | 111.53% | -334.90% | -31.51% | 383.16% | 24.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.39% | -48.73% | -34.10% | 1,275.90% | 4,117.89% |